Navidea Biopharmaceuticals INAVBQ
13F holders, Q1 2024 (March 31)2holders
$0.04avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Navidea Biopharmaceuticals I (NAVBQ) in their 13F filings. The largest holders were Parallel Advisors, LLC ($13) and WR Wealth Planners, LLC ($0).
- Company
- Navidea Biopharmaceuticals I
- CUSIP
- 63937X202
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 3 | $450 |
Ownership 2 holders
| Parallel Advisors, LLC | 0.00% | No change | 350 | $13 |
| WR Wealth Planners, LLC | 0.00% | New | 10 | $0 |
"% of holder's portfolio" is NAVBQ's weight in each manager's 13F, not the share of Navidea Biopharmaceuticals I the manager owns.